Abstract:Background Previous studies have reported that inflammation, especially interleukin family members, plays an important role in the development of colorectal cancer (CRC). However, because of various confounders and the lack of clinical randomized controlled trial, the causal relationship between genetically predicted level of interleukin family and CRC risk has not been fully explained. Objective Bi‐directional Mendelian randomization (MR) was conducted to investigate the causal association between interleukin family members and CRC. Methods Several genetic variables were extracted as instrumental variables (IVs) from summary data of genome‐wide association studies (GWAS) for interleukin and CRC. IVs of interleukin family were obtained from recently published GWAS studies and the summary data of CRC was from FinnGen Biobank. After a series of quality control measures and strict screening, six models were used to evaluate the causal relationship. Pleiotropy, heterogeneity test, and a variety of sensitivity analysis were also used to estimate the robustness of the model results. Results Genetically predicted higher circulating levels of IL‐2 (odds ratio [OR]: 0.76; 95% confidence interval [CI]: 0.63–0.92; p = .0043), IL‐17F(OR: 0.78; 95% CI: 0.62–1.00; p = .015), and IL‐31 (OR: 0.88; 95% CI: 0.79–0.98; p = .023) were suggestively associated with decreased CRC risk. However, higher level of IL‐10 (OR: 1.40; 95% CI: 1.18–1.65; p = .000094) was causally associated with increased risk of CRC. Reverse MR results indicated that the exposure of CRC was suggestively associated with higher levels of IL‐36α (OR: 1.23; 95% CI: 1.01–1.49; p = .040) and IL‐17RD (OR: 1.22; 95% CI, 1.00–1.48; p = .048) and lower level of IL‐13 (OR: 0.78; 95% CI: 0.65–0.95; p = .013). The overall MR results did not provide evidence for causal relationships between other interleukins and CRC (p > .05). Conclusion We offer suggestive evidence supporting a potential causal relationship between circulating interleukins and CRC, underscoring the significance of targeting circulating interleukins as a strategy to mitigate the incidence of CRC.

Association between inflammatory factors and melanoma: a bidirectional Mendelian randomization study

Mendelian Randomization As an Approach to Assess Causal Effects of Inflammatory Bowel Disease on Atrial Fibrillation.

Causal Relationship Between Inflammatory Bowel Disease and Malignant Melanoma: A Mendelian Randomization Analysis

Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis

Exploration of the causal relationship between inflammatory cytokines and prostate carcinoma: a comprehensive Mendelian randomization study

Causal relationship between inflammatory skin diseases and breast cancer: A bidirectional Mendelian randomization study

Inflammatory Bowel Disease and Skin Cancer: A Two-Sample Mendelian Randomization Analysis

CRP, IL-1α, IL-1β, and IL-6 levels and the risk of breast cancer: a two-sample Mendelian randomization study

A Mendelian Randomization Study of Genetic Liability to Cutaneous Melanoma and Sunburns

The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin‐derived deteriorated tumors

Causal Relationships Between Inflammatory Factors and Multiple Myeloma: A Bidirectional Mendelian Randomization Study

Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study

Inflammatory factors and risk of meningiomas: a bidirectional mendelian-randomization study

Systemic inflammatory regulators and age-related macular degeneration: a bidirectional Mendelian randomization study

Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study

Genetic association of circulating interleukins and risk of colorectal cancer: A bidirectional Mendelian randomization study

Causal relationship between the gut microbiome and basal cell carcinoma, melanoma skin cancer, ease of skin tanning: evidence from three two-sample mendelian randomisation studies

The causality between systemic inflammatory regulators and chronic respiratory diseases: A bidirectional Mendelian-randomization study

Causal association between skin cancer and immune cells: mendelian randomization (MR) study

Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis

Genetically Predicted Systemic Inflammation and the Risk of Atrial Fibrillation: A Bidirectional Two-Sample Mendelian Randomization Study